Date Filed | Type | Description |
10/12/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
10/12/2023 |
8-K
| Quarterly results |
10/05/2023 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Amendments to Articles of Incorporation ...
Docs:
|
"Certificate of Designations of Series X Convertible Preferred Stock",
"Any voluntary termination of employment by Rajiv De Silva, Domenic Della Penna or Hemanth Varghese will result in an event of default unless proper notice is provided to CNB and a replacement acceptable to CNB is hired within 90 days",
"Any voluntary termination of employment by Rajiv De Silva, Domenic Della Penna or Hemanth Varghese will result in an event of default unless proper notice is provided to CNB and a replacement acceptable to CNB is hired within 90 days",
"Any voluntary termination of employment by Rajiv De Silva, Domenic Della Penna or Hemanth Varghese will result in an event of default unless proper notice is provided to CNB and a replacement acceptable to CNB is hired within 90 days",
"Any voluntary termination of employment by Rajiv De Silva, Domenic Della Penna or Hemanth Varghese will result in an event of default unless proper notice is provided to CNB and a replacement acceptable to CNB is hired within 90 days",
"Subordination of Debt Agreement, by and between Venus Concept Ltd., Madryn Health Partners, LP, Madryn Health Partners (Cayman Master), LP and City National Bank of Florida",
"Any voluntary termination of employment by Rajiv De Silva, Domenic Della Penna or Hemanth Varghese will result in an event of default unless proper notice is provided to CNB and a replacement acceptable to CNB is hired within 90 days",
"As of October 24, 2023, Venus USA must have a deposit ledger balance with CNB of not less than $3,000,000. Thereafter, commencing with the month ending November 30. 2023, Borrower must maintain a minimum average daily deposit ledger balance (which may include deposit accounts of its affiliates to the extent maintained with CNB or subject to an account control agreement in favor of CNB) of at least $3,000,000 as of the end of each month. Venus USA has the ability to cure breaches of this covenant which occur on or prior to March 31, 2024 by raising additional capital within 14 days following the applicable test date" |
|
08/14/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
08/14/2023 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
07/14/2023 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
07/14/2023 |
SC 13D/A
| EW Healthcare Partners, L.P. reports a 50.7% stake in Venus Concept, Inc. |
07/12/2023 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits ... |
06/02/2023 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
05/31/2023 |
SD
| Form SD - Specialized disclosure report: |
05/26/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
05/24/2023 |
SC 13D/A
| EW Healthcare Partners, L.P. reports a 42% stake in Venus Concept, Inc. |
05/24/2023 |
D
| Form D - Notice of Exempt Offering of Securities: |
05/15/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
05/15/2023 |
8-K
| Quarterly results |
05/11/2023 |
8-K
| Material Modifications to Rights of Security Holders, Submission of Matters to a Vote of Security Holders, Financial Statemen... |
03/27/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
03/27/2023 |
8-K
| Quarterly results |
03/20/2023 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
03/07/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
02/07/2023 |
8-K
| Results of Operations and Financial Condition, Departure of Directors or Certain Officers; Election of Directors; Appointment... |
01/06/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
01/03/2023 |
SC 13D/A
| Longitude Capital Partners II, LLC reports a 5% stake in VENUS CONCEPT INC. |
12/21/2022 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
12/19/2022 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
12/14/2022 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
11/30/2022 |
D
| Form D - Notice of Exempt Offering of Securities: |
11/29/2022 |
SC 13D/A
| EW Healthcare Partners, L.P. reports a 40.6% stake in Venus Concept, Inc. |
11/28/2022 |
SC 13D/A
| EW Healthcare Partners, L.P. reports a 41.4% stake in Venus Concept, Inc. |
11/23/2022 |
SC 13D/A
| HealthQuest Partners II, L.P. reports a 15.8% stake in Venus Concept, Inc. |
11/23/2022 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
11/21/2022 |
SC 13D/A
| MASTERS CAPITAL MANAGEMENT LLC reports a 26.5% stake in Venus Concept Inc. |
11/18/2022 |
8-K
| Quarterly results |
11/10/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
|